Valuation: LifeMD, Inc.

Market Cap 159M 137M 129M 117M 221M 15.13B 224M 1.51B 592M 7.57B 595M 582M 25.25B P/E 2026 *
-6.34x
P/E 2027 * -62.2x
Enterprise Value 159M 137M 129M 117M 221M 15.13B 224M 1.51B 592M 7.57B 595M 582M 25.25B EV / Sales 2026 *
0.76x
EV / Sales 2027 * 0.65x
Free-Float
85.86%
Yield 2026 *
-
Yield 2027 * -
1 day-2.66%
1 week-10.60%
Current month-6.00%
1 month-29.09%
3 months-23.13%
6 months+17.50%
Current year-3.52%
1 week 3.2
Extreme 3.1964
3.71
1 month 3
Extreme 3
4.79
Current year 2.56
Extreme 2.56
5.38
1 year 2.56
Extreme 2.56
7.32
3 years 2.56
Extreme 2.56
15.84
5 years 1.14
Extreme 1.14
15.84
10 years 0.42
Extreme 0.421
33.02
Manager TitleAgeSince
Chief Executive Officer 39 2025-07-31
Director of Finance/CFO 57 2026-03-15
Chief Tech/Sci/R&D Officer - 2026-05-31
Director TitleAgeSince
Chairman 65 -
Director/Board Member 75 2014-09-03
Chairman 43 2019-06-10
Date Insider Type Main position Quantity % Market Cap.
12/9/25 Sell

Executive/Senior Manager

15,000 0.0312%
10/6/25
Strawn Pickens LLP
OtherCompany 0 0%
10/6/25 Free

Director

22,365 0.0516%
Change 5-day change 1-year change 3-year change Capi.($)
-2.66%-10.60%-51.83%-24.89% 159M
+2.08%+13.11%-12.32%+24.42% 39.23B
+0.46%+2.55%-38.57%+162.18% 13.43B
+3.24%+4.56%-19.49%+73.81% 5.65B
+1.05%+9.86%-0.17% - 2.57B
+5.75%+4.14% - - 1.94B
+0.73%-0.11%+17.72%-44.12% 1.69B
+0.69%-0.83%-37.48% - 1B
-1.71%-0.65%+35.00%+125.00% 908M
+1.36%+1.08%-31.43%-44.66% 857M
Average +1.10%+1.87%-15.40%+38.82% 6.74B
Weighted average by Cap. +1.80%+8.60%-17.14%+57.31%

Financials

2026 *2027 *
Net sales 208M 180M 168M 154M 289M 19.8B 293M 1.98B 775M 9.91B 779M 762M 33.05B 245M 212M 199M 181M 341M 23.37B 346M 2.34B 914M 11.7B 920M 900M 39.02B
Net income -24.83M -21.51M -20.15M -18.38M -34.56M -2.37B -35.09M -237M -92.66M -1.19B -93.22M -91.19M -3.95B -2.68M -2.32M -2.17M -1.98M -3.72M -255M -3.78M -25.54M -9.98M -128M -10.04M -9.83M -426M
Net Debt - -
Logo LifeMD, Inc.
LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.
Employees
350
Date Price Change Volume
26-08-12 US$3.290 -2.66% 893,171
26-08-11 US$3.380 -6.63% 1,070,356
26-08-10 US$3.620 +1.69% 2,230,335
26-08-07 US$3.560 +4.71% 1,265,525
26-08-06 US$3.400 -7.61% 4,975,533
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
3.290USD
Average target price
8.125USD
Spread / Average Target
+146.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LFMD Stock